The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)
Status:
Recruiting
Trial end date:
2021-09-15
Target enrollment:
Participant gender:
Summary
Multicenter study to evaluate the safety and tolerability in patients with wet Age-related
macular degeneration (wAMD) treated with intravitreal recombinant humanized anti-VEGF
monoclonal antibody